Fidelity Disruptive Medicine ETF (NASDAQ:FMED) Stock Short Interest Report for October

Fidelity Disruptive Medicine ETF (NASDAQ:FMED) was the recipient of a large decline in short interest during the month of October. As of October 15th, there was short interest totaling 1,699 shares, a decline of 76.4% from the September 30th total of 7,209 shares. Currently, 0.1% of the company’s stock are short sold. Based on an average daily volume of 8,969 shares, the days-to-cover ratio is presently 0.2 days.

Hedge Funds Weigh In On Fidelity Disruptive Medicine ETF

A hedge fund recently bought a new position in Fidelity Disruptive Medicine ETF stock. Root Financial Partners LLC bought a new stake in shares of Fidelity Disruptive Medicine ETF (NASDAQ:FMED) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 1,291 shares of the company’s stock, valued at approximately $42,000. Root Financial Partners LLC owned about 0.08% of Fidelity Disruptive Medicine ETF at the end of the most recent quarter.

Fidelity Disruptive Medicine ETF Price Performance

Fidelity Disruptive Medicine ETF stock traded up $0.72 during mid-day trading on Wednesday, reaching $33.24. The stock had a trading volume of 9,445 shares, compared to its average volume of 10,647. The company has a market capitalization of $53.18 million, a price-to-earnings ratio of 41.33 and a beta of 0.76. The company has a 50-day moving average price of $31.69 and a two-hundred day moving average price of $27.72. Fidelity Disruptive Medicine ETF has a one year low of $23.48 and a one year high of $33.30.

Fidelity Disruptive Medicine ETF Company Profile

The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is managed by Fidelity.